1- or 3-monosubstituted 2-oxindole compound intermediates useful for the production of analgesic and anti-inflammatory agents
CA 1289556 C · Owner: Pfizer Limited · Inventors: Kadin, Saul Bernard
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed are novel 1- or 3-monosubstituted 2-oxindole compounds useful as intermediates for the preparation of analgesic and anti-inflammatory 1,3-disubstituted 2-oxindole compounds. The intermediates have the formulae: and , The 1,3-disubstituted 2-oxindole compounds have the formula: X is H, halo, alkyl, alkoxy, alkylthio CF3, alkylsulfinyl, alkylsulfonyl, nitro phenyl, alkanoyl, benzoyl, thenoyl, alkanamido, benzamido or N,N-dialkylsulfamoyl; Y is H halo, alkyl, alkoxy, cycloalkyl, alkylthio or CF3; or X and Y together form methylenedioxy, ethylenedioxy or with the carbon atoms to which they are attached, a cycloalkane or aromatic ring; R1 is alkyl cycloalkyl, phenyl, phenylalkyl, …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted September 24, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended September 24, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.